Abstract In this study, we evaluated the association between prenatal depression symptoms adverse birth outcomes in African-American women. We conducted a retrospective cohort study of 261 pregnant African-American women who were screened with the Edinburgh Postnatal Depression Scale (EPDS) at their initial prenatal visit. Medical records were reviewed to assess pregnancy and neonatal outcomes, specifically preeclampsia, preterm birth, intrauterine growth retardation, and low birth weight. Using multivariable logistic regression models, an EPDS score ≥10 was associated with increased risk for preeclampsia, preterm birth, and low birth weight. An EPDS score ≥10 was associated with increased risk for intrauterine growth retardation, but after controlling for behavioral risk factors, this association was no longer significant. Patients who screen positive for depression symptoms during pregnancy are at increased risk for multiple adverse birth outcomes. In a positive, patient-rated depression screening at the initial obstetrics visit, depression is associated with increased risk for multiple adverse birth outcomes. Given the retrospective study design and small sample size, these findings should be confirmed in a prospective cohort study.
Introduction
Depression is a risk factor for suboptimal pregnancy outcomes (Kiely et al. 2011) . With up to 30 % of pregnant women experiencing significant depressive symptoms (Gavin et al. 2005; Marcus 2008; Marcus et al. 2005) , research regarding the impact of depressive symptoms on obstetrical outcomes has been the focus of a number of studies. A recent metaanalysis reported that antenatal depression is independently associated with an increased risk for preterm birth (PTB) and low birth weight (LBW), but not intrauterine growth restriction (IUGR) (Grote et al. 2010) . The authors likened the risk of antenatal depression on birth outcomes to smoking 10 or more cigarettes per day. Although the exact relationship between depression and adverse birth outcomes is currently unknown, it has been suggested that increased corticotropin-releasing hormone (CRH) in depression may lead to PTB (Straub et al. 2012; Wadhwa et al. 2004) . Other studies have shown an association between preeclampsia and depressive symptoms (Kurki et al. 2000) or a diagnosis of depression (Cripe et al. 2011; Kharaghani et al. 2012; Qiu et al. 2009 ). Preeclampsia, characterized by hypertension, proteinuria, and edema, occurs in 5-8 % of births and is estimated to be responsible for 15 % of preterm births (Kanasaki and Kalluri 2009) . Potentially common mechanisms linking depression and preeclampsia include hypothalamicpituitary axis dysfunction, impaired immune activation, and activation of vasoactive hormones (Cripe et al. 2011) .
Although important and necessary, diagnosing depression in a large obstetrical practice can be logistically difficult. While clinician-administered diagnostic instruments are the gold standard, they are time consuming and staff intensive to administer. Conversely, patient-rated screening instruments are easier to use but may have lower sensitivity and specificity. Because adverse obstetrical outcomes can have significant, long-term, negative health impacts, it would be useful to know how well a simple, patient-rated screening for depression at the initial obstetric visit predicts the risk of adverse pregnancy outcomes. To begin to answer this question, we examined a cohort of pregnant women in a general obstetrics clinic with the aim of determining if a depression screening performed at a patient's initial obstetric visit was associated with adverse pregnancy outcomes. The objective was to see if a known screening tool could be effectively utilized to inform obstetrical practices about the risk of depression on adverse pregnancy outcomes, such as preeclampsia, preterm birth, intrauterine growth retardation, and low birth weight.
Materials and methods
Five hundred women presenting for their initial prenatal visit from November 2008 to April 2009 were asked to complete the Edinburgh Postnatal Depression Scale (EPDS) (Cox et al. 1996) to assess current symptoms of depression. Of this cohort, we analyzed delivery data from black, non-Hispanic women with singleton births past 20 weeks gestational age who delivered at the University of Pennsylvania, resulting in a cohort of 261 women. The EPDS is a patient-rated depression screening tool widely validated in both pregnant and postpartum women that consists of 10 questions scored from 0 to 3 with a maximum score of 30. Scores ≥10 are consistent with clinical depression, and further evaluation is recommended (Evins et al. 2000; Jardri et al. 2006; Lee et al. 2001) . The study population was derived from an urban, hospital-based clinic at the University of Pennsylvania in which the majority of patients are insured by Medicaid (95 %). Prior to initiation, this study was approved by the University of Pennsylvania Institutional Review Board.
All records were deidentified prior to data extraction. Researchers blinded to EPDS scores reviewed the medical records of the subjects to determine maternal and neonatal pregnancy outcomes. Both paper and electronic charts were reviewed to collect all information. The primary outcome variables were preeclampsia (per the medical record as hypertension and proteinuria), PTB (gestational age at birth <37 weeks gestational age), IUGR (weight <10th percentile for gestational age), and LBW (birth weight <2,500 g at delivery). These outcomes were chosen a priori based on a review of the literature. All outcomes were coded as dichotomous variables with the unaffected group coded as the reference group.
Demographic characteristics and the prevalence of risk factors for adverse birth outcomes were calculated for the full sample. To determine risk factors associated with each specific birth outcome, t tests were used to compare the groups on continuous risk factors, and chi-square tests were used to compare groups on categorical risk factors (Fisher's exact test was used when the sample size for a given risk factor resulted in expected cell values <5). Risk factors assessed included demographic variables (age and parity), psychological risk factors (EPDS scores ≥10), a history of mental illness noted on the patient's problem list, known psychotropic exposure during pregnancy, medical/obstetric risk factors (chronic illness noted on the patient's problem list, history of prior preterm birth, gestational diabetes, or thyroid disease during the current pregnancy), and behavioral risk factors (known alcohol use at initial clinic visit, known recreational drug use during pregnancy, and smoking reported at initial clinic visit). A series of multivariable logistic regression models were then used to evaluate the association of potential risk factors with the risk for preeclampsia, PTB, IUGR, and LBW. Variables were considered for the multivariable model if the risk factor was associated with the outcome at p<0.10 in univariate analyses. Demographic variables (age and parity) were included in each model. Separate models were calculated for each outcome variable. For categorical variables included in the logistic regression models, the unexposed group was used as the reference group. We considered a p value <0.05 in the final models to be statistically significant.
Results
Characteristics of the sample screened with the EPDS have been published elsewhere (Kim et al. 2011) . Briefly, 94 % of the cohort agreed to respond to the EPDS, and 95 % were insured by Medicaid. Given that the majority of the women in our general clinic population are African-American (83.3 %), we a priori chose to restrict our sample to 261 AfricanAmerican women with a live, singleton birth, for whom delivery data were available, to enhance the homogeneity of the population. It is well documented that the rates of preterm birth, preeclampsia, and low birth weight in the USA are higher for non-Hispanic black women than for non-Hispanic white women (www.cdc.gov/nchs/data/databriefs/db74.htm, http://www.cdc.gov/pednss/pdfs/PNSS_2009.pdf). Characteristics of the sample are presented in Table 1 . The mean age was 24.6 years (SD=5.4), with a range of 18-44 years. The mean gestational age at EPDS screening was 17. 2 weeks (SD=7.4), with a range of 6.14-38.86 weeks. The mean birth weight was 3,152.0 g (SD=587.9), and the mean gestational age at delivery was 38.9 weeks (SD=2.2). For the 260 woman for whom there was parity data, just under one quarter of subjects were primiparous (23.0 %, n=60) while the majority were multiparous (76.6 %, n=200). A history of mental illness was noted in 17.2 % of the subjects' medical records. The most common mental illnesses were depression (n=39), bipolar disorder (n=7), and anxiety disorders (n=8). Six subjects (2.3 %) were known to have been exposed to psychotropic medications during pregnancy; medications included antidepressants, benzodiazepines, antipsychotics, and antiepileptics. A history of chronic illness was noted in nearly half (49.0 %) of the subjects' medical records. The most common chronic illnesses were asthma (n=56) and hypertension (n=12). Sixty-one women (23.3 %) experienced at least one adverse outcome (preeclampsia, LBW, PTB, or IUGR). Half of these women experienced only one adverse outcome (n=31), 20 women experienced two adverse outcomes, 6 women experienced three adverse outcomes, and 4 women experienced all four adverse outcomes.
Risk factors for preeclampsia
Of the 254 women for whom the presence or absence of preeclampsia during the current pregnancy was recorded, 25 (9.6 %) were classified as having preeclampsia. Table 2 presents characteristics associated with preeclampsia in this sample. Women who received a diagnosis of preeclampsia had higher EPDS scores and were more likely to have EPDS scores ≥10. Table 3 presents the results of a multivariable logistic regression model predicting preeclampsia. Three variables were included in the model: maternal age, parity, and EPDS scores ≥10. An EPDS score ≥10 was the only significant risk factor for preeclampsia (OR 2.95, 95 % CI 1.26-6.89).
To account for the possibility that preeclampsia developed prior to depression, we performed a post hoc analysis restricting the sample to women who completed the EPDS at gestational ages less than 20 weeks only and for whom information regarding preeclampsia was available (n=162). EPDS scores ≥10 remained significantly associated with an increased risk of preeclampsia (OR 5.21, 95 % CI 1.69-16.03).
Risk factors for preterm birth
Of the 251 women for whom gestational age at delivery was reported, 28 (11.2 %) gave birth before 37 weeks gestational age. Table 2 presents characteristics associated with PTB in this sample.
Mothers of preterm infants were more likely to have been diagnosed with thyroid disease during the current pregnancy and more likely to have a history of prior PTB. There was also a nonsignificant trend for mothers of preterm infants to have higher EPDS scores and to be more likely to have EPDS scores ≥10.
The multivariable logistic regression model for predicting preterm birth is presented in Table 3 . Five variables were included in the model: maternal age, parity, EPDS scores ≥10, history of prior preterm birth, and thyroid disease during the current pregnancy. Three risk factors were significantly associated with risk for preterm birth: EPDS scores ≥10 (OR 2.34, 95 % CI 1.03-5.36), thyroid disease during the current pregnancy (OR 7.79, 95 % CI 1.52-39.99), and history of prior preterm birth (OR 3.35, ).
Risk factors for IUGR <10 %
Of the 212 women for whom the presence or absence IUGR <10 % was recorded, 26 (10 %) were classified as having IUGR during the current pregnancy. Table 2 presents characteristics associated with IUGR <10 % in this sample. 
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Women with IUGR <10 % were more likely to have EPDS scores ≥10 and were more likely to have reported smoking at their initial clinic visit. There was a nonsignificant trend for women with IUGR <10 % to have higher EPDS scores and to be more likely to have used recreational drugs during pregnancy. Table 3 presents the results of two multivariable logistic regression models predicting IUGR <10 %. Three variables were included in the initial model: maternal age, parity, and EPDS scores ≥10. EPDS scores ≥10 were significantly associated with IUGR <10 % (OR 2.91, 95 % CI 1.26-6.72).
Two behavioral risk factors for IUGR <10 %, smoking during the current pregnancy and known recreational drug use during the current pregnancy, were not included in the initial model. As both recreational drug use during the current pregnancy and smoking reported at the initial clinic visit were associated with IUGR <10 % at p<0.10 in univariate analyses, a separate logistic regression model was conducted to assess whether including these behavioral risk factors, in addition to demographic risk factors and depressive symptoms, explained further variance in IUGR <10 %. After including these additional risk factors in the model, there was a trend for EPDS scores ≥10 to be associated with IUGR <10 % (OR 2.32, 95 % CI 0.96-5.58), but this result was no longer statistically significant (p=0.06). There was also a trend for smoking reported at the initial clinic visit to be associated with IUGR <10 % (OR 2.82, 95 % CI 0.91-8.79), but this result was not statistically significant (p=0.07).
Risk factors for low birth weight
Of the 214 subjects for whom birth weight of the infant was reported, 22 (8.4 %) were classified as low birth weight (<2,500 g). Table 2 presents characteristics associated with low birth weight in this sample. Mothers of LBW infants had higher EPDS scores and were more likely to have EPDS scores ≥10.
The multivariable logistic regression model predicting low birth weight is presented in Table 3 . Three variables were included in the model: maternal age, parity, and EPDS scores ≥10. EPDS scores ≥10 were significantly associated with LBW (OR 2.90, 95 % CI 1.18-7.13).
Comment
In this study population, a simple, patient-rated depression screen was significantly associated with increased risk for preeclampsia, preterm birth, and low birth weight. Approximately one third (34.9 %) of our sample screened positive for depression, which is a rate similar to prior studies (Kiely et al. 2011; Marcus 2008; Scholle et al. 2003) . Antenatal depression is more common in African-American, single, and lower socioeconomic status women (Kiely et al. 2011) , and the rates have increased significantly over the past decade (Maguire et al. 2009 ). This group is also at increased risk for adverse birth outcomes, which may be partially explained by the increased depression risk.
Twenty-five (9.6 %) women in our total sample were diagnosed with preeclampsia per the medical record. This rate is higher than expected as the baseline rate of preeclampsia in African-American women is 3 % (http://www.cdc. gov/pednss/pdfs/PNSS_2009.pdf). Women with elevated levels of depressive symptoms were three times more likely to be diagnosed with preeclampsia. In another study that examined antenatal depressive symptoms and the subsequent development of preeclampsia, depression was associated with a 2.5-fold increase in preeclampsia (OR 2.5, 95 % CI 1.1-5.4) (Kurki et al. 2000) . This sample of nulliparous, Caucasian women was screened with a different measure of depression symptoms (Beck Depression Inventory) at a mean earlier gestational age (12 weeks). Three studies that evaluated the association between a diagnosis of depression and preeclampsia have found a positive association. The first study reported that women with a diagnosis of a depression during pregnancy as per the medical record had an increased risk of preeclampsia (OR 2.72, 95 % CI 1.29-5.74) (Qui et al. 2009 ). Another study that used diagnosis of antenatal depression in the medical record as the main criterion had an elevated risk of preeclampsia close to our results (OR 3.57, 95 % CI 1.83-6.99) (Cripe et al. 2011) . Lastly, moderate to severe antenatal depression (retrospectively assessed) was associated with an increased risk of preeclampsia in an Iranian cohort (OR 2.52, 95 % CI 1.05-6.02) (Kharaghani et al. 2012) . However, other studies have not found an association between antenatal depression and preeclampsia (Andersson et al. 2004; Vollebregt et al. 2008) . The use of antidepressants during pregnancy may also be associated with an increased risk of preeclampsia although the use of psychotropics may be a proxy for more severe depression (Palmsten et al. 2012; Qui et al. 2009 ). The association between antenatal depression and preeclampsia could be direct or indirect. Depression may directly affect vascular resistance (Kurki et al. 2000) , but it is more likely that there may be characteristics or common underlying mechanisms in both antenatal depression and preeclampsia such as obesity, elevated corticotropin-releasing hormone (De Bonis 2012), or an impaired inflammatory response to pregnancy (Cripe et al. 2011) . While antenatal depression may exacerbate the presentation of preeclampsia, the genesis of preeclampsia occurs early in pregnancy during implantation and therefore is unlikely to be causative.
In our total sample, the preterm birth rate was 11.2 %, which is lower than the national average for non-Hispanic black infants (17.5 %) (http://www.cdc.gov/nchs/data/nvsr/ nvsr60/nvsr60_01.pdf). This may be due to the fact that we sampled from a group seeking prenatal care. Factors associated with PTB in our sample were depressive symptoms, thyroid disease, and a history of PTB. The results of a metaanalysis on the subject found that depression scores were significantly associated with PTB (RR 1.13, 95 % CI 1.06-1. 21) (Grote et al. 2010) . For every one point increase in depression score, there was an associated 3 % increase in the risk of PTB. Of the five studies published since the metaanalysis, three show similar results. Van Dijk et al. (2010) screened 4,044 women over 22 weeks gestational age with the Center for Epidemiologic Scale for Depression (CES-D) and found a significant association between depression and PTB (8.4 vs. 4.5 %, p<0.05). In another study, depression was associated with an increased rate of PTB (12 vs. 6.3 %, p=0.05) ). Smith et al. (2011) found an increase in PTB in women with depression (OR 1.82, 95 % CI 1.17-2.86) in a sample of women participating in the Healthy Start initiative. Finally, in a recent study, women screened with the EPDS at 24-28 weeks gestational age had an increased risk of PTB if their EPDS score was ≥12 (OR 1. 3, 96 % CI 1.09-1.35) (Straub et al. 2012) . However, Wang and Chen (2010) did not find an association, but their baseline PTB rate in their nondepressed cohort was high at 20 % making it more difficult to find a difference between the groups. Goedhart et al. (2010) screened 8,050 pregnant women with the CES-D and did not find depression (defined as CES-D >16) to be associated with PTB. We defined LBW categorically as neonates <2,500 g. Twenty-two women (8. 4 %) in our sample had a LBW infant. Women with an EPDS score ≥10 were significantly more likely to have a LBW infant. In the meta-analysis by Grote et al. (2010) , the relative risk of LBW in women with antenatal depression was increased by 49 % when both LBW and depression were dichotomized as categorical variables. All studies published since the Grote meta-analysis defined LBW as a continuous variable, making it difficult to compare to our study. Field et al. (2009) screened 390 black women at 18-22 weeks gestational and found that women with major depressive disorder were more likely to have an infant with LBW (p=0.05). Diego et al. (2009) looked at whether another depression screening scale (CES-D) could predict which group would be more at risk for adverse birth outcomes in a prospective, case-control design. The depressed group, evaluated at 18-22 weeks GA, had higher CES-D scores, were younger, less likely to be married, and of lower SES status. Women with depression were more likely to have a LBW infant (OR 4.74, ). Their depressed cohort had slower fetal growth across the second half of pregnancy. Wang and Chen (2010) did not find an association between high EPDS scores and LBW in a sample of 431 women. This sample was predominately middle to upper socioeconomic status which led the authors to conclude that this sample may have had good prenatal care potentially compensating for the impact of depression on birth outcomes. Twenty-six women (10 %) in our sample had IUGR which was not associated with antenatal depression once smoking and recreational drug use were controlled for confirming data published in the Grote et al. meta-analysis (2010) .
Overall, our data show that women with a positive depression screen during pregnancy are at increased risk for a range of adverse birth outcomes. The ideal time to screen is not known. The biological links between depression and adverse birth outcomes are not completely understood. It is possible that depression leads to poor health behaviors, increasing the risk of adverse outcomes. Depressed women are more likely to smoke and abuse substances and are less likely to seek prenatal care (Bonari et al. 2004; Chen and Lin 2011) . We found that elevated EPDS scores were no longer a significant predictor of IUGR <10 % after controlling for smoking and recreational drug use during pregnancy, while there was a trend for smoking to be associated with IUGR, which suggests that the relationship between depressive symptoms and IUGR may be mediated by negative health behaviors such as smoking. Other possible factors that could lead to an adverse obstetric outcome in depressed women include poor nutritional status (Hurley et al. 2005) , elevated prepregnancy body mass index (BMI) (Kiely et al. 2011) , and the use of psychotropic medications (Udechuku et al. 2010) . It has been posited that depression causes or results from hypothalamic-pituitary-adrenal axis dysregulation, which leads to an abnormal uterine environment (Magiakou et al. 1997; Kammerer et al. 2006; Steiner et al. 2003) . For example, stress-related increases in corticotropin and/or corticotropin-releasing hormone CRH could lead to an abnormally earlier triggering of the parturition clock, leading to PTB. Or, depression may be caused by increased stress, which in term may in turn increase blood pressure, cause vasoconstriction, decrease uterine blood flow and fetal hypoxia, and elevate CRH, increasing the risk of adverse pregnancy outcomes (Holzman et al. 2001; Wadhwa et al. 2001) . Finally, high levels of emotional distress are associated with depressed lymphocyte activity in pregnant women, increasing vulnerability to urogenital and amniotic infections and premature rupture of membranes (Herrara et al. 1998; Newton et al. 2001) . These hypotheses are yet to be definitively confirmed.
Strengths of this study include the use of a standardized depression scale that is validated for use during pregnancy. The population sample was purposely restricted to women with similar demographics to control for the effect of demographic characteristics on adverse obstetrical outcomes. The study also mimics the reality of clinical care such that women come in at different gestational ages for first appointments, and screening at a single gestational age is unrealistic in most clinical settings. Limitations of this study include our inability to confirm data beyond chart review. We were unable to confirm a diagnosis of depression in this sample. Also, we could not include BMI as a variable because maternal weight was unpredictably recorded in the medical records. BMI is a risk factor for both preterm birth and preeclampsia. Infection has also been associated with preeclampsia, but we did not collect this information. Inclusion of BMI and infection may have decreased the association between depressive symptoms and preeclampsia although bacterial vaginosis did not change this association in a previous study (Kurki et al. 2000) . Since prepregnancy BMI tends to be larger in depressed cohorts, its impact on the association tends to negligible (Kharaghani et al. 2012; Qiu et al. 2009) . A larger, prospective study evaluating women across pregnancy would be necessary to confirm our results. In conclusion, our study joins the increasing data showing that depression during pregnancy may have a negative impact on fetal outcomes.
